OP8 A New Complement Inhibitor: Impact of Ravulizumab on Eculizumab and Future Biosimilars Use, and Role of Paris Public Hospitals (AP-HP).
- Resource Type
- Article
- Source
Value in Health . 2023 Supplement, Vol. 26 Issue 12, pS443-S443. 1p.- Subject
- Language
- ISSN
- 1098-3015